Niagen Bioscience (NAGE) Change in Cash (2011 - 2026)

Niagen Bioscience (NAGE) has reported Change in Cash for 16 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Cash fell 83.93% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $10.9 million (down 61.02% YoY), while the FY2025 annual figure was $20.1 million, up 16.11% from the prior year.
• Change in Cash grew to $1.8 million in Q1 2026 per NAGE's latest filing, from $498000.0 in the prior quarter.
• Across five years, Change in Cash topped out at $12.3 million in Q4 2024 and bottomed at -$7.2 million in Q1 2022.
• Historically, Change in Cash has averaged $2.3 million across 5 years, with a median of $1.8 million in 2026.
• Annual changes were most pronounced in 2022 — Change in Cash slumped 125.81% — and 2025, when it soared 4465.0%.
• Niagen Bioscience's Change in Cash stood at $7.2 million in 2022, then sank by 92.31% to $552000.0 in 2023, then jumped by 2121.38% to $12.3 million in 2024, then sank by 95.94% to $498000.0 in 2025, then soared by 253.61% to $1.8 million in 2026.
• Business Quant data shows NAGE's Change in Cash at $1.8 million in Q1 2026, $498000.0 in Q4 2025, and $3.8 million in Q3 2025.